Results 341 to 350 of about 823,617 (410)
Some of the next articles are maybe not open access.
Autologous Bone Marrow Transplantation
Critical Reviews in Clinical Laboratory Sciences, 1995Autologous bone marrow transplantation has become a very popular and successful treatment for many patients with lymphomas and other malignancies. The current indications, pretreatment regimes, and laboratory manipulations are discussed as well as the application of gene transfer to eliminate selected genetic diseases and detect disease relapse.
Leo J. McCarthy +5 more
openaire +2 more sources
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Bone marrow transplantation retinopathy
International Ophthalmology, 2001Bone marrow transplantion (BMT) is the treatment of choice for both malignant and nonmalignant disorders of the bone marrow. BMT retinopathy occurs after a latent period of 6 months and usually recovers after a few weeks.We present a case of BMT retinopathy (BMT) in a patient with a high-degree of non-Hodgkin lymphoma.
F, Gómez-Ulla +3 more
openaire +2 more sources
Autologous Bone Marrow Transplantation
Annual Review of Medicine, 1989Autologous bone marrow transplantation in the acute leukemias and lymphomas offers potentially curative treatment in patients who do not have a histocompatible, allogeneic donor. Results of marrow autografting in the lymphomas are especially encouraging, with disease-free survivals of 50-60% in patients who have failed primary and secondary treatment ...
G W, Santos, A M, Yeager, R J, Jones
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 1985
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone Marrow Transplant Retinopathy
American Journal of Ophthalmology, 1991Five of eight patients (62%) who survived at least six months after autologous or allogeneic bone marrow transplantation for acute leukemia developed occlusive microvascular retinopathy. Treatable retinal microangiopathy included a high incidence (80%) of clinically significant macular edema and one case of proliferative retinopathy with subhyaloid ...
P F, Lopez +5 more
openaire +2 more sources
Bone marrow transplantation today
Supportive Care in Cancer, 1994Today, bone marrow transplantation (BMT) is an established therapy. This statement is best verified by the number of BMTs performed. Between January 1990 and December 1992, 172 European teams in 26 countries carried out a total of 14,334 transplants. There were 6642 allogeneic transplants: 5513 BMT from an HLA-identical sibling donor, 370 from a non ...
openaire +2 more sources
Bone Marrow Purging for Autologous Bone Marrow Transplantation
Leukemia & Lymphoma, 1993High dose therapy with the resulting myeloablation rescued by infusion of autologous bone marrow (ABMT) has become a major treatment option for an increasing number of patients with hematologic and solid tumors. ABMT has several potential advantages over allogeneic transplantation.
J G, Gribben, L M, Nadler
openaire +2 more sources
Rehabilitation following bone marrow transplantation
Cancer, 2000Bone marrow transplantation and stem cell transplantation are increasingly used to treat hematologic malignancies and some solid tumors. The treatment entails bone marrow-ablative therapies and intensive medical support to sustain the patient through pancytopenia and other complications of the disease, transplantation process, or drug side effects ...
T A, Gillis, E S, Donovan
openaire +2 more sources
Pediatric Bone Marrow Transplantation
Pediatrics In Review, 1991Bone marrow transplantation is a high-visibility, high-technology discipline with a growing list of potentially curative applications in neoplastic, hematologic, immunologic, and genetic diseases of children. The clinical problems experienced by children who have received bone marrow grafts involve pediatricians in both general and subspecialty ...
openaire +2 more sources